Cutaneous reaction to naproxen

Allergologia et Immunopathologia

Volumn 24, Issue 2, 1996, Pages 89-92

  Gonzalo Garijo, M A ^a   Bobadilla Gonzalez P ^b  

^a HOSPITAL INFANTA CRISTINA   (Spain)

^b Hospital Don Benito   (Spain)

Author keywords

Cross reactions; Drug eruptions; Fixed drug eruption; Naproxen; Non steroidal antiinflammatory drugs; NSAID; Patch tests; Propionic acid derivatives

Indexed keywords

DIAGNOSTIC AGENT; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROPIONIC ACID DERIVATIVE;

ADULT; ASTHMA; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG ERUPTION; DYSMENORRHEA; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATCH TEST; PIGMENT DISORDER; PRURITUS; REVIEW; SKIN DISEASE;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; DRUG ERUPTIONS; DYSMENORRHEA; FACIAL DERMATOSES; FEMALE; HUMANS; NAPROXEN; PATCH TESTS; PIGMENTATION DISORDERS; PROPIONIC ACIDS; PRURITUS;

EID: 0030090187     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Biscarini L Anti-inflammatory analgesics and drugs used in gout In. Dukes M N G. (Ed). Meyler's Side Effects of Drugs, 12th Edition. Amsterdam: Elsevier, 1992; 181-234.
2. Bigby M and Stern R. Cutaneous reactions to nonsteroidal antiinflammatory drugs J Am Acad Dermatol 1985; 12: 866-876.
3. Habbema L and Bruynzeel D P. Fixed drug eruption due to naproxen. Dermatologica 1987; 174: 184-185
4. Van Arsdel P.P. Jr. Adverse drug reactions. In. Middleton E. Jr , Reed C E , Ellis E.F (Eds). Allergy. Principles and Practice, VoI II, 2nd edition. St Louis The C V. Mosby Company, 1983; 1389-1414.
5. Teraki Y , Moriya N and Shiohara T. Drug-induced expression of intercellular adhesion molecule-1 on lesional keratinocytes in fixed drug eruption. Am J Pathol 1994; 145(3): 550-560.
6. Pellicano R , Ciavarella C., Lomuto M. and Di Giorgio G. Genetic susceptibility to fixed drug eruption, evidence for a link with HLA-B22. J Am Acad Dermatol 1994; 30(1): 52-54.
7. Ophaswongse S. and Maibach H. Topical nonsteroidal antiinflammatory drugs: allergic and photoallergic contact dermatitis and phototoxicity. Contact Dermatitis 1993; 29(2): 57-64.
8. Alanko K., Stubb S. and Reitamo S. Topical provocation of fixed drug eruption. Br J Dermatol 1987; 116: 561-567.
9. Kauppinen K. and Stubb S. Fixed eruptions' causative drugs and challenge tests. Br J Dermatol 1985; 112: 575-578.
10. Jerez J., Martín-Gil D., Jiménez I., Rodríguez F., Antón E., Garcés M. and Duque S. Fiabilidad de las pruebas diagnósticas en el exantema fijo, eritema muftiforme y necrolisis epidémica (síndrome de Lyell) por medicamentos. Rev Esp Alergol Inmunol Clin 1988; 3: 48-55.
11. Herrero T , De Barrio M., Pelta R et al Reactividad cruzada del grupo paraamino Rev Esp Alergol Inmunol Clin 1990; 5 (Supl 2): 74-80.
12. Alanko K. Topical provocation of fixed drug eruption: A study of 30 patients. Contact Dermatitis 1994; 31 (1) 25-27.
13. DiPiro J.T., Talbert R.L., Hayes P.E., Yee G.C. and Posey L M Pharmacotherapy. A Pathophysiologic Approache, New York, Elsevier, 1989; 972.
14. Carrington D M , Earl H.S. and Sullivan T.J. Studies of human IgE to a sulfonamide determinant. J Allergy Clin Immunol 1987; 79: 442-447